|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0032743,
umls-concept:C0231174,
umls-concept:C0238198,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C0935989,
umls-concept:C1176020,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-1-19
|
|
pubmed:abstractText |
Positron emission tomography with (18)F-fluorodeoxyglucose (FDG-PET) was used to evaluate treatment response in patients with gastrointestinal stromal tumors (GIST) after administration of sunitinib, a multitargeted tyrosine kinase inhibitor, after imatinib failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-kit,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Platelet-Derived Growth...,
http://linkedlifedata.com/resource/pubmed/chemical/imatinib,
http://linkedlifedata.com/resource/pubmed/chemical/sunitinib
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BenhattarJeanJ,
pubmed-author:DelaloyeAngelika BischofAB,
pubmed-author:ElsigValérieV,
pubmed-author:GuillouLouisL,
pubmed-author:LeyvrazSergeS,
pubmed-author:LuthiFrançoisF,
pubmed-author:MichielinOlivierO,
pubmed-author:MontemurroMichaelM,
pubmed-author:OrcurtoMaria-VictoriaMV,
pubmed-author:PriorJohn OJO,
pubmed-author:StuppRogerR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
439-45
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:19064982-Adult,
pubmed-meshheading:19064982-Aged,
pubmed-meshheading:19064982-Antineoplastic Agents,
pubmed-meshheading:19064982-Disease Progression,
pubmed-meshheading:19064982-Drug Resistance, Neoplasm,
pubmed-meshheading:19064982-Female,
pubmed-meshheading:19064982-Fluorodeoxyglucose F18,
pubmed-meshheading:19064982-Gastrointestinal Stromal Tumors,
pubmed-meshheading:19064982-Humans,
pubmed-meshheading:19064982-Indoles,
pubmed-meshheading:19064982-Male,
pubmed-meshheading:19064982-Middle Aged,
pubmed-meshheading:19064982-Mutation,
pubmed-meshheading:19064982-Piperazines,
pubmed-meshheading:19064982-Positron-Emission Tomography,
pubmed-meshheading:19064982-Protein-Tyrosine Kinases,
pubmed-meshheading:19064982-Proto-Oncogene Proteins c-kit,
pubmed-meshheading:19064982-Pyrimidines,
pubmed-meshheading:19064982-Pyrroles,
pubmed-meshheading:19064982-Receptor, Platelet-Derived Growth Factor alpha,
pubmed-meshheading:19064982-Salvage Therapy
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
|
|
pubmed:affiliation |
Nuclear Medicine Department,Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland John.Prior@chuv.ch
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|
